Boiron SA (EPA:BOI)
France · Delayed Price · Currency is EUR 29.00
+0.50 (1.75%)
May 14, 2026, 5:35 PM CET
Boiron Revenue
In the year 2025, Boiron had annual revenue of 501.11M EUR with 2.78% growth. Boiron had revenue of 255.46M in the half year ending December 31, 2025, with 0.83% growth.
Revenue
501.11M
Revenue Growth
+2.78%
P/S Ratio
0.99
Revenue / Employee
200.52K
Employees
2,634
Market Cap
494.82M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 501.11M | 13.55M | 2.78% |
| Dec 31, 2024 | 487.56M | -5.69M | -1.15% |
| Dec 31, 2023 | 493.25M | -40.99M | -7.67% |
| Dec 31, 2022 | 534.24M | 79.04M | 17.36% |
| Dec 31, 2021 | 455.20M | -58.38M | -11.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 47.35B |
| EssilorLuxottica Société anonyme | 28.49B |
| Ipsen | 3.93B |
| Sartorius Stedim Biotech | 2.98B |
| LNA Santé | 912.67M |
| Vetoquinol | 525.70M |
| Lumibird | 228.53M |
| Equasens Société anonyme | 224.73M |